biomarkers, tumor

Performance evaluation and clinical impact of the Oncomine Myeloid Research Assay for gene expression analysis in myeloid haematologic malignancies
Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Ha Nui Kim, Jeong Ah Kwon, Soo-Young Yoon, Jung Yoon

Journal of Clinical Pathology Aug 2022, jclinpath-2022-208425; DOI: 10.1136/jcp-2022-208425
Benchmarking bioinformatics approaches for tumour mutational burden evaluation from a large cancer panel against whole-exome sequencing
Jiuhong Pang, Hongai Xia, Shijun Mi, Wen Zhang, Danielle Pendrick, Christopher Freeman, Helen Fernandes, Mahesh Mansukhani, Susan J Hsiao

Journal of Clinical Pathology Jul 2022, jclinpath-2022-208385; DOI: 10.1136/jcp-2022-208385
Automatic CD30 scoring method for whole slide images of primary cutaneous CD30⁺ lymphoproliferative diseases
Tingting Zheng, Song Zheng, Ke Wang, Hao Quan, Qun Bai, Shuqin Li, Ruiqun Qi, Yue Zhao, Xiaoyu Cui, Xinghua Gao

Journal of Clinical Pathology Jul 2022, jclinpath-2022-208344; DOI: 10.1136/jcp-2022-208344
Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients
Emmanuel Khalifa, Caroline Chapusot, Benjamin Tournier, Julie Sentis, Estelle Marion, Alicia Remond, Manon Aubry, Célia Pioche, Anthony Bergeron, Charlotte Primois, Larry Blanchard, Alice Millière, Marlène Boucheix, Yannick Léger, Marine Bairrao, Véronique Brouste, Laurent Martin, Isabelle Soubeyran

Journal of Clinical Pathology Jul 2022, jclinpath-2022-208325; DOI: 10.1136/jcp-2022-208325
Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Andrew R Clamp, Jurjees Hasan, Claire Mitchell, Zena Salih, Emma R Woodward, Fiona Lalloo, Joseph Shaw, Sudha Desai, Emma J Crosbie, Richard J Edmondson, Helene Schlecht, Andrew J Wallace, Gordon C Jayson, D Gareth R Evans

Journal of Clinical Pathology Jun 2022, jclinpath-2022-208369; DOI: 10.1136/jcp-2022-208369
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma
Steffen Deichmann, Leif Schindel, Rüdiger Braun, Louisa Bolm, Martin Taylor, Vikram Deshpande, Oliver Schilling, Peter Bronsert, Tobias Keck, Cristina Ferrone, Ulrich Wellner, Kim Honselmann

Journal of Clinical Pathology Apr 2022, jclinpath-2022-208176; DOI: 10.1136/jclinpath-2022-208176
FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing
Susan D Richman, Gemma Hemmings, Helen Roberts, Niall Gallop, Rachel Dodds, Lyndsay Wilkinson, Jonathan Davis, Rhian White, Emma Yates, Bharat Jasani, Louise Brown, Tim S Maughan, Rachel Butler, Philip Quirke, Richard Adams

Journal of Clinical Pathology Mar 2022, jclinpath-2022-208233; DOI: 10.1136/jclinpath-2022-208233
Real-world programmed death-ligand 1 prevalence rates in non-small cell lung cancer: correlation with clinicopathological features and tumour mutation status
Mikaela Holmes, Annabelle Mahar, Trina Lum, Steven Kao, Wendy Anne Cooper

Journal of Clinical Pathology Feb 2021, 74 (2) 123-128; DOI: 10.1136/jclinpath-2020-206709
Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer
Tara Spence, Sheron Perera, Jessica Weiss, Sylvie Grenier, Laura Ranich, Frances Shepherd, Tracy L Stockley

Journal of Clinical Pathology Feb 2021, 74 (2) 91-97; DOI: 10.1136/jclinpath-2020-206668
Proteomic biomarkers in Gaucher disease
Łukasz Pawliński, Ewa Tobór, Maciej Suski, Maria Biela, Anna Polus, Beata Kieć-Wilk

Journal of Clinical Pathology Jan 2021, 74 (1) 25-29; DOI: 10.1136/jclinpath-2020-206580

Main menu

biomarkers, tumor

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

biomarkers, tumor

Pages